HARROW, INC. — Director's Dealing 2013

Mar 18, 2013

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Imprimis Pharmaceuticals, Inc. (IMMY)
CIK: 0001360214
Period of Report: 2012-07-12

Reporting Person: Miloni Donald Paul (10% Owner)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	878576	Direct
Common Stock	25316	Indirect
Common Stock	151898	Indirect
Common Stock	101265	Indirect

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Warrants	$5.925	2017-04-25	Common Stock (15282)		Direct
Warrants	$5.925	2017-04-25	Common Stock (6329)		Indirect
Warrants	$5.925	2017-04-25	Common Stock (37975)		Indirect
Warrants	$5.925	2017-04-25	Common Stock (25370)		Indirect

Footnotes

F1: The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.